Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
47.84
-0.88 (-1.81%)
Feb 21, 2025, 4:00 PM EST - Market closed
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 244 employees as of December 31, 2023. The number of employees increased by 157 or 180.46% compared to the previous year.
Employees
244
Change (1Y)
157
Growth (1Y)
180.46%
Revenue / Employee
$531,234
Profits / Employee
-$550,586
Market Cap
1.83B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
TARS News
- 1 day ago - Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025 - GlobeNewsWire
- 22 days ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care - GlobeNewsWire
- 2 months ago - Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks - Seeking Alpha
- 3 months ago - Tarsus Pharmaceuticals, Inc. (TARS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors - GlobeNewsWire
- 3 months ago - Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 - GlobeNewsWire
- 3 months ago - Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer - GlobeNewsWire